Abstract
No public abstract is available from the verified source records.
Kuohai Fan, Abdul Haseeb, Fida Noor, Huizhen Yang, Panpan Sun, Zhenbiao Zhang, Jia Zhong, Jianzhong Wang, Yaogui Sun, Hongquan Li
Abstract
Authors
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Canine mammary cancer: state of the art and future perspectives
10.3390/ani13193147 · 2023
Epidemiological investigation of canine mammary tumors in mainland China between 2017 and 2021
10.3389/fvets.2022.843390 · 2022
Risk factor analysis and clinicopathological characteristics of female dogs with mammary tumours from a single-center retrospective study in Poland
10.1038/s41598-024-56194-z · 2024
Epidemiology and classification for canine and feline mammary gland tumors: a histopathological survey of 437 mammary gland tumor biopsies performed in a secondary care hospital in Chiang Mai, Thailand from 2012 to 2019
10.7717/peerj.17077 · 2024
Prognostic significance of immunohistochemical markers and histological classification in malignant canine mammary tumours
10.1111/vco.12603 · 2020
Histopathological, immunohistochemical and imaging features of bone metastases of mammary carcinoma in bitches: cases report
10.29374/2527-2179.bjvm009124 · 2025
Canine mammary tumors: classification, biomarkers, traditional and personalized therapies
10.3390/ijms25052891 · 2024
Canine mammary tumors as a promising adjunct preclinical model for human breast cancer research: similarities, opportunities, and challenges
10.1007/s12272-024-01524-y · 2025
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
Current research status of anti-cancer peptides: mechanism of action, production, and clinical applications
10.1016/j.biopha.2023.114996 · 2023
Anticancer activities of natural antimicrobial peptides from animals
2023
Antimicrobial peptides as potential therapeutics for breast cancer
10.1016/j.phrs.2021.105777 · 2021
Anticancer potential of antimicrobial peptides: focus on breast cancer
10.1002/jbt.70525 · 2025
Effect of NK-lysin peptides on bacterial growth, MIC, antimicrobial resistance, and viral activities
10.1080/10495398.2023.2290520 · 2024
Expression and purification of the recombinant porcine NK-lysin in Pichia pastoris and observation of anticancer activity in vitro
10.1080/10826068.2014.979206 · 2016
Recombinant porcine NK-lysin inhibits the invasion of hepatocellular carcinoma cells in vitro
10.1016/j.ijbiomac.2019.08.212 · 2019
Porcine recombinant NK-lysin inhibits the growth and metastasis of murine hepatocellular carcinoma in vivo
10.3390/molecules30061234 · 2025
Enhanced anti-tumor efficacy of prNK-lysin delivered by injectable pH-responsive hydrogel in the treatment of orthotopic breast cancer
10.1016/j.ijbiomac.2025.149754 · 2026
Molecular principles of metastasis: a hallmark of cancer revisited
10.1038/s41392-020-0134-x · 2020
Movers and shakers: cell cytoskeleton in cancer metastasis
10.1111/bph.12704 · 2014
Cytoskeletal dynamics in epithelial-mesenchymal transition: insights into therapeutic targets for cancer metastasis
10.3390/cancers13081882 · 2021
Roles of cytoskeleton in metastasis: from its mechanism to therapeutic strategies
10.1038/s12276-025-01608-9 · 2026
Microtubule dynamics in cancer metastasis: harnessing the underappreciated potential for therapeutic interventions
10.1016/j.pharmthera.2024.108726 · 2024
Mechanical tumor microenvironment and transduction: cytoskeleton mediates cancer cell invasion and metastasis
10.7150/ijbs.44943 · 2020
High eEF1A1 protein levels mark aggressive prostate cancers and the in vitro targeting of eEF1A1 reveals the eEF1A1-actin complex as a new potential target for therapy
10.3390/ijms23084143 · 2022
The eEF1A protein in cancer: clinical significance, oncogenic mechanisms, and targeted therapeutic strategies
10.1016/j.phrs.2024.107195 · 2024
The role of the molecular chaperone CCT in protein folding and mediation of cytoskeleton-associated processes: implications for cancer cell biology
10.1007/s12192-018-0949-3 · 2019
Advances in the study of CCT3 in malignant tumors: a review
10.1097/md.0000000000041069 · 2025
Cyclopedic protein expression analysis of cultured canine mammary gland adenocarcinoma cells from six tumours
10.1016/j.rvsc.2005.07.011 · 2006
Pore-forming peptides: a new treatment option for Cancer
10.2174/0929867328666211126150055 · 2022
Advances in antimicrobial peptides: promising cancer treatments and vaccines
10.3389/fmed.2026.1783547 · 2026
Anticancer peptides mechanisms, simple and complex
10.1016/j.cbi.2022.110194 · 2022
The cytoskeleton and cancer
10.1007/s10555-008-9166-3 · 2009
Filopodia in vitro and in vivo
10.1146/annurev-cellbio-020223-025210 · 2023
The crossroads between RAS and RHO signaling pathways in cellular transformation, motility and contraction
10.3390/genes12060819 · 2021
RhoA-ROCK2 signaling possesses complex pathophysiological functions in cancer progression and shows promising therapeutic potential
10.1186/s12935-024-03519-7 · 2024
Vinculin and metavinculin: oligomerization and interactions with F-actin
10.1016/j.febslet.2013.02.042 · 2013
Nuclear α-actinin-4 regulates breast cancer invasiveness and EMT
10.1002/cm.21901 · 2025
ERM proteins support perinuclear actin rim formation
2025
ERM proteins in cancer progression
10.1242/jcs.133108 · 2014
The cofilin pathway in breast cancer invasion and metastasis
10.1038/nrc2148 · 2007
CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer
10.1038/s41419-019-1894-5 · doi-reference
An E3 ligase network engages GCN1 to promote the degradation of translation factors on stalled ribosomes
10.1016/j.cell.2022.12.025 · doi-reference
MEK mediates v-Src-induced disruption of the actin cytoskeleton via inactivation of the rho-ROCK-LIM kinase pathway
10.1074/jbc.m202261200 · doi-reference
RAF-MEK-ERK pathway in cancer evolution and treatment
10.1016/j.semcancer.2021.05.010 · doi-reference
Chaperonin containing TCP-1 subunit 3 is critical for gastric cancer growth
10.18632/oncotarget.22838 · doi-reference
Suppression of CCT3 inhibits the proliferation and migration in breast cancer cells
10.1186/s12935-020-01314-8 · doi-reference
eEF1A1 promotes colorectal cancer progression and predicts poor prognosis of patients
10.1002/cam4.4848 · doi-reference
Cofilin promotes vasculogenic mimicry by regulating the actin cytoskeleton in human breast cancer cells
10.1002/1873-3468.14594 · doi-reference